Megalabs USA, a subsidiary of Megalabs, that manufactures, markets and distributes pharmaceutical products and nutritional supplements throughout the Americas, has added two new products, Abintra and Glutapak R, to its North American portfolio.
These additions join the brand's other science-based nutritional products, which include Enterex Diabetic, a nutritionally complete, high-protein shake specially formulate for for people with diabetes, and Prunelax, a popular lineup of laxative supplements.
Products like Abintra and Glutapak R support optimal nutrition in cases when it matters most
Megalabs USA CEO, Fabian Rivero, said the portfolio expansion further supports the company's mission. "We are passionate about creating products that improve the lives of our customers," Rivero said. "These new products offer proven, evidence-based therapies, and I couldn't be prouder to bring them to our North American markets."
Abintra is Megalabs USA's nutritional supplement formulated to help heal wounds. Although it's an often-overlooked aspect of wound care, nutrition is a key factor for healing. Abintra features a unique combination of arginine, glutamine, high-quality protein, and antioxidant vitamins and minerals in a quick-dissolving powder. The formula works to promote tissue synthesis and wound healing from within.
These new products offer proven, evidence-based therapies
Glutapak R is a probiotic glutamine supplement for gut health and intestinal healing. Glutapak R is currently the only therapeutic intestinal product on the market that both restores healthy microflora in the gut with a clinically proven probiotic and helps to repair intestinal damage with glutamine. Though the products have just launched, they are already seeing positive reviews, especially among healthcare providers.
"As physicians have long known, proper nutrition is a key aspect of wellness," Rivero said. "Products like Abintra and Glutapak R support optimal nutrition in cases when it matters most, which is why we've seen such a positive reception for them within the healthcare community."
